Plasma Cell Myeloma
Showing NaN - NaN of 9
Plasma Cell Myeloma Trial in United States (Ixazomib Citrate, Lenalidomide, Placebo Administration)
Recruiting
- Plasma Cell Myeloma
- Ixazomib Citrate
- +4 more
-
Phoenix, Arizona
- +221 more
Jan 28, 2023
Plasma Cell Myeloma Trial in Israel, United States (Laboratory Biomarker Analysis, Lenalidomide, Melphalan)
Active, not recruiting
- Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +5 more
-
Mobile, Alabama
- +392 more
Jan 25, 2023
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,
Active, not recruiting
- Acute Biphenotypic Leukemia
- +18 more
- Cyclophosphamide
- +8 more
-
Aurora, Colorado
- +2 more
Dec 28, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Financial Difficulty in Chronic Lymphocytic Leukemia and
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Plasma Cell Myeloma
- Medical Chart Review
- +3 more
-
Anchorage, Alaska
- +115 more
Aug 2, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Plasma Cell Myeloma Trial in Puerto Rico, United States (Bortezomib, Carfilzomib, Dexamethasone)
Active, not recruiting
- Plasma Cell Myeloma
- Bortezomib
- +5 more
-
Anchorage, Alaska
- +919 more
Dec 29, 2021
Plasma Cell Myeloma, Plasmacytosis, Recurrent Plasma Cell Myeloma Trial in Aurora (Melphalan, Bortezomib, Dexamethasone)
Terminated
- Plasma Cell Myeloma
- +3 more
- Melphalan
- +3 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Feb 23, 2015